Logo

American Heart Association

  136
  0


Final ID: Sa2186

Association of histologic findings with long-term outcomes in symptomatic obstructive hypertrophic cardiomyopathy patients undergoing surgical myectomy

Abstract Body (Do not enter title and authors here): Background: In hypertrophic cardiomyopathy (HCM), histologic findings like myocyte hypertrophy & disarray, interstitial fibrosis (IF) & small intramural coronary arteriole dysplasia (SICAD) account for the left ventricular hypertrophy, diastolic dysfunction, arrhythmogenicity & microvascular ischemia.
Objectives: To evaluate the association between histology & outcomes in obstructive HCM (oHCM) patients undergoing surgical myectomy (SM).
Methods: This was an observational study of 1722 symptomatic oHCM patients (mean age 56±14 years, 948 [55%] men) who underwent SM at a tertiary care center between 2005-18. Baseline clinical data was collected. The SM specimen was analyzed for presence & severity of a) myocyte hypertrophy b) myocyte disarray c) IF & d) SICAD. Histologic findings were graded as 0-3 (none, mild, moderate, & severe) & a score from 0-12 was calculated. Primary endpoint was a composite of death, appropriate defibrillator discharge or cardiac transplantation during follow-up.
Results: 896 (52%) were in New York Heart Association (NYHA) class III/IV, 457 (21%) had exertional syncope, 727 (42%) had ≥1 sudden death risk factor & 409 (24%) had atrial fibrillation (AF). Moderate & severe histologic findings were distributed as follows: myocyte hypertrophy (1341 [78%]), disarray (237 [14%]), IF (448 [26%]) & SICAD (258 [15%]). The mean total histologic score was 5.1±1.4. At 5.1±5.2 years, there were 352 (20%) primary events (317 [18%] deaths). On spline analysis (Figure 1A), a total histology score of ≥ 6 was associated with primary events. On Kaplan-Meier analysis (Figure 1B), patients with a histology score ≥ 6 had greater events vs. those with a score <6 (147/598 [25%] vs. 205/1124 [18%], log-rank p-value 0.002). On multivariable Cox analysis, age (for 10-year increase, Hazard ratio or HR 1.49 [95% confidence interval or CI 1.35-1.65], p<0.001), NYHA Class III/IV (HR 1.58 [95% CI -1.25-2.01], p<0.001), AF (HR 1.65 [95% CI 1.30-2.10], p<0.001) & histology score ≥6 (HR 1.24 [95% CI 1.03-1.54], p=0.03) were independently associated with higher primary events.
Conclusions: In symptomatic oHCM patients undergoing SM, a higher histologic score was independently associated with long-term outcomes.
  • Jadam, Shada  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Popovic, Zoran  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Desai, Milind  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Gaballa, Andrew  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Alashi, Alaa  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Xu, Bo  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Thamilarasan, Maran  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Rodriguez, E  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Tan, Carmela  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Ospina, Susan  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Smedira, Nicholas  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Author Disclosures:
    Shada Jadam: DO NOT have relevant financial relationships | Zoran Popovic: DO NOT have relevant financial relationships | Milind Desai: DO have relevant financial relationships ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:Edgewise:Active (exists now) ; Consultant:Viz AI:Active (exists now) ; Consultant:Tenaya:Active (exists now) | Andrew Gaballa: DO NOT have relevant financial relationships | Alaa Alashi: DO NOT have relevant financial relationships | Bo Xu: DO have relevant financial relationships ; Speaker:Bristol Myers Squibb:Active (exists now) | Maran Thamilarasan: DO NOT have relevant financial relationships | E Rodriguez: DO NOT have relevant financial relationships | Carmela Tan: DO NOT have relevant financial relationships | Susan Ospina: DO have relevant financial relationships ; Speaker:Bristol Myers Squibb:Active (exists now) | Nicholas Smedira: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cardiomyopathy Potpourri 1

Saturday, 11/16/2024 , 02:00PM - 03:00PM

Abstract Poster Session

More abstracts on this topic:
A Cellular Mechanism Mediating Lipomatous Metaplasia In the Infarcted Heart.

Tuleta Izabela, Frangogiannis Nikolaos, Venugopal Harikrishnan, Huang Shuaibo, Humeres Claudio, Hernandez Velasco Silvia, Hanna Anis, Kubota Akihiko, O'leary Kevin, Zheng Deyou

Assessment of Adverse Left Ventricular Remodeling Following Ischemia Reperfusion Injury with SPECT Imaging Agent Targeting Fibroblast Activation Protein

Thorn Stephanie, Duncan James S, Spinale Francis, Luna Gutierrez Myrna, Ferro-flores Guillermina, Sinusas Albert, Porcaro Olivia, Burns Rachel, Zohora Fatema Tuj, Guerrera Nicole, Jang Sun-joo, Vermillion Billy, Lima Moroni, Liu Chi

More abstracts from these authors:
Characteristics and Long-Term Outcomes of Asymptomatic Patients with Hypertrophic Cardiomyopathy Undergoing Treadmill Stress Echocardiography

Sultana Sana, Popovic Zoran, Desai Milind, Jadam Shada, Abusafia Mohammed, Gaballa Andrew, Ospina Susan, Rutkowski Kathryn, Xu Bo, Smedira Nicholas, Wierup Per

Long-Term Outcomes of Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical Myectomy: Is an Earlier Intervention Better?

Jadam Shada, Smedira Nicholas, Desai Milind, Sultana Sana, Abusafia Mohammed, Gaballa Andrew, Ospina Susan, Rutkowski Kathryn, Xu Bo, Popovic Zoran, Wierup Per

You have to be authorized to contact abstract author. Please, Login
Not Available